SCPH

SC Pharmaceuticals

Price

chg

quotes and stock data delayed 15 minutes

Cash

$119.3M

Burn Rate (Qtr)

$8.3M

Mkt Cap

mkt cap api

52 wk hi

52 wk low

low api

high api

*cash/burn updated:

Q3 '20

Company Profile

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing innovative solutions to enhance the potential of outpatient care.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

Furoscix

Heart Failure Treatment

FDA Type A meeting & NDA Resubmission

​

​

​

Recent Posts

See what the community is saying - click to see full post

Biopharma Stock Updates - 12/07/2020

SCPH - scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

SCPH - PDUFA Date for FUROSCIX®

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

​

  • Twitter Social Icon
  • LinkedIn Social Icon